Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

NOTV

Inotiv Inc

Feb 13 • 04:00PM ET

0.2848

-0.0054 -1.86 %

Healthcare • Diagnostics & Research • USA • NASD

Feb 13, 4:36 PMInotiv issues a detailed public notice dated Feb. 13, 2026 on its August 2025 cybersecurity incident, disclosing potential compromise of extensive personal data and outlining remediation and monitoring measures for affected individuals.

Peers: CRL ICON IQV MEDP CROX CERS BMRN CTLT EXEL NBIX

| Held by: VTI VXF IWC PRFZ

Index	-	P/E	-	EPS (ttm)	-2.02	Insider Own	9.56%	Shs Outstand	34.39M	Perf Week	-31.91%
Market Cap	9.80M	Forward P/E	-	EPS next Y	-1.81	Insider Trans	-3.56%	Shs Float	31.11M	Perf Month	-53.16%
Enterprise Value	473.04M	PEG	-	EPS next Q	-0.64	Inst Own	22.80%	Short Float	6.46%	Perf Quarter	-74.57%
Income	-69.37M	P/S	0.02	EPS this Y	-7.35%	Inst Trans	-2.20%	Short Ratio	2.46	Perf Half Y	-84.52%
Sales	514.03M	P/B	0.09	EPS next Y	20.09%	ROA	-9.21%	Short Interest	2.01M	Perf YTD	-49.33%
Book/sh	3.17	P/C	0.77	EPS next 5Y	-	ROE	-49.76%	52W High	4.51 -93.69%	Perf Year	-92.39%
Cash/sh	0.37	P/FCF	-	EPS past 3/5Y	46.54% -37.40%	ROIC	-41.61%	52W Low	0.29 -1.79%	Perf 3Y	-96.15%
Dividend Est.	-	EV/EBITDA	24.28	Sales past 3/5Y	-2.15% 53.36%	Gross Margin	12.69%	Volatility	14.50% 11.15%	Perf 5Y	-98.26%
Dividend TTM	-	EV/Sales	0.92	EPS Y/Y TTM	56.09%	Oper. Margin	-7.01%	ATR (14)	0.05	Perf 10Y	-79.66%
Dividend Ex-Date	-	Quick Ratio	0.21	Sales Y/Y TTM	8.19%	Profit Margin	-13.50%	RSI (14)	20.42	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.30	EPS Q/Q	18.83%	SMA20	-38.06%	Beta	4.24	Target Price	3.25
Payout	-	Debt/Eq	4.37	Sales Q/Q	0.84%	SMA50	-51.63%	Rel Volume	0.82	Prev Close	0.29
Employees	2046	LT Debt/Eq	0.53	Earnings	Feb 09 BMO	SMA200	-80.40%	Avg Volume	816.77K	Price	0.28
IPO	Nov 25, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	-30.09% -0.02%	Trades		Volume	668,586	Change	-1.86%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-24	Downgrade	Jefferies	Buy → Hold	$11.50 → $3.75
Feb-09-24	Upgrade	Jefferies	Hold → Buy	$3 → $11.50
Jul-20-23	Initiated	Wells Fargo	Overweight	$9
Jan-19-23	Downgrade	Jefferies	Buy → Hold	$10 → $8
Jan-11-23	Upgrade	Lake Street	Hold → Buy	$4 → $10
Nov-18-22	Downgrade	Lake Street	Buy → Hold	$60 → $7
Oct-04-22	Initiated	Jefferies	Buy	$27
Jan-31-22	Initiated	Lake Street	Buy	$60
Sep-20-21	Initiated	Craig Hallum	Buy	$45

Feb-13-26 04:30PM	Inotiv Provides Notice Regarding Cybersecurity Incident (GlobeNewswire)
Feb-09-26 07:00AM	Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update (GlobeNewswire) -13.63%
Feb-04-26 06:30AM	Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026 (GlobeNewswire) -6.83%
Jan-13-26 09:15AM	Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery (GlobeNewswire)
Dec-11-25 09:00AM	Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities (GlobeNewswire)
06:05PM	Loading…
Dec-04-25 06:05PM	Inotiv Inc (NOTV) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Cybersecurity Challenges (GuruFocus.com) -6.53% -8.10%
Dec-03-25 04:05PM	Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update (GlobeNewswire) +8.13%
Nov-25-25 07:00AM	Inotiv Ranked Number 182nd Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500 (GlobeNewswire)
Nov-21-25 07:00AM	Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025 (GlobeNewswire)
Nov-17-25 04:05PM	Inotiv, Inc. Announces Preliminary Fiscal 2025 Fourth Quarter and Full Year Results (GlobeNewswire) -33.20% +24.62%
Oct-24-25 10:20AM	Halper Sadeh LLC Encourages Inotiv, Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Oct-21-25 04:05PM	Inotiv, Inc. to Participate in Three Investor Conferences in November 2025 (GlobeNewswire)
Aug-20-25 07:37AM	Pharmaceutical firm Inotiv investigating ransomware attack that disrupted operations (Cybersecurity Dive)
Aug-13-25 07:00AM	Inotiv, Inc. to Participate in Three Investor Conferences in September 2025 (GlobeNewswire)
Aug-06-25 09:16PM	CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update (GlobeNewswire) +5.54% -10.50%
05:50PM	Loading…
05:50PM	Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update (GlobeNewswire)
Aug-05-25 07:15AM	Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-23-25 07:00AM	Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025 (GlobeNewswire) +7.14%
May-22-25 04:05PM	Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025 (GlobeNewswire)
May-08-25 03:28AM	Inotiv Inc (NOTV) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Optimizations ... (GuruFocus.com) +10.20%
12:05AM	Inotiv outlines revised RMS site optimization plan with $6.5M investment and $6M-$7M annual savings projection (Seeking Alpha)
12:03AM	Inotiv, Inc. (NOTV) Q2 2025 Earnings Call Transcript (Seeking Alpha)
May-07-25 06:45PM	Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +14.20%
04:05PM	Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update (GlobeNewswire)
May-06-25 08:45AM	Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates (Zacks) -13.73%
May-01-25 10:01AM	Will Nektar Therapeutics (NKTR) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-30-25 10:01AM	Inotiv, Inc. (NOTV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-23-25 04:05PM	Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025 (GlobeNewswire) +7.27% +8.47%
Feb-06-25 02:14AM	Inotiv Inc (NOTV) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... (GuruFocus.com) -6.22%
04:05PM	Loading…
Feb-05-25 04:05PM	Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update (GlobeNewswire) -7.01%
Jan-22-25 04:05PM	Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025 (GlobeNewswire)
Dec-30-24 04:05PM	Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million (GlobeNewswire) -11.06%
Dec-23-24 04:05PM	Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million (GlobeNewswire) +14.97%
Dec-18-24 08:00AM	Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares (GlobeNewswire) -28.83%
Dec-17-24 04:03PM	Inotiv, Inc. Launches Proposed Public Offering of Common Shares (GlobeNewswire)
Dec-04-24 02:00AM	Inotiv Inc (NOTV) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Operational Challenges (GuruFocus.com) -6.21%
Dec-03-24 04:05PM	Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update (GlobeNewswire) +7.44%
Dec-02-24 07:02AM	Inotiv Inc (NOTV) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +6.56%
Nov-21-24 08:30AM	Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500 (GlobeNewswire) +6.23%
Nov-20-24 04:05PM	Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024 (GlobeNewswire) +15.05%
Nov-07-24 08:00AM	Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences (GlobeNewswire) +8.23%
Oct-09-24 05:54PM	Inotiv Inc (NOTV) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... (GuruFocus.com)
Sep-16-24 08:00AM	Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity (GlobeNewswire) +18.97%
Aug-28-24 04:05PM	Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference (GlobeNewswire) +9.29%
Aug-08-24 06:15PM	Inotiv, Inc. (NOTV) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +5.66%
04:05PM	Inotiv Reports Third Quarter Financial Results for Fiscal 2024 and Provides Business Update (GlobeNewswire)
Jul-25-24 08:00AM	Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024 (GlobeNewswire)
Jul-09-24 06:50AM	3 Breakout Stocks to Buy Before They Make Headlines (InvestorPlace)
Jul-01-24 10:20AM	3 Undervalued Stocks Primed for a 2X Return (InvestorPlace)
Jun-10-24 07:30AM	Inotiv, Inc. Provides Business Updates (GlobeNewswire) +6.43%
Jun-03-24 02:49PM	Company that bred beagles for research pleads guilty to neglect, ordered to pay record $35M fine (Associated Press Finance) +16.04%
01:24PM	Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility (GlobeNewswire)
May-23-24 04:15PM	Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences (GlobeNewswire)
May-15-24 09:54PM	NOTV Stock Earnings: Inotiv Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace) +5.66%
04:05PM	Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update (GlobeNewswire)
May-14-24 08:19AM	Why Is Inotiv (NOTV) Stock Down 35% Today? (InvestorPlace) -49.16%
07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
07:00AM	Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024 (GlobeNewswire)
May-10-24 05:20AM	Inotiv Delays Release of Fiscal Q2 Results (MT Newswires) -9.62%
May-09-24 06:56PM	Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results (GlobeNewswire) -12.42%
Apr-29-24 04:05PM	Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024 (GlobeNewswire) -7.65%
Apr-03-24 08:50AM	Inotiv (NOTV) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Apr-02-24 08:50AM	Why Fast-paced Mover Inotiv (NOTV) Is a Great Choice for Value Investors (Zacks)
Mar-25-24 09:40AM	Is Inotiv (NOTV) a Great Value Stock Right Now? (Zacks)
Mar-18-24 08:50AM	Here's Why Momentum in Inotiv, Inc. (NOTV) Should Keep going (Zacks)
Mar-12-24 04:42PM	Rocket Stocks: 3 Picks That Could Skyrocket Your Portfolio by 2025 (InvestorPlace) +9.96%
Mar-07-24 04:20PM	3 Stocks That Could Fast-Track Your Millionaire Status (InvestorPlace) +6.54%
12:00PM	Inotiv, Inc. (NOTV) is a Great Momentum Stock: Should You Buy? (Zacks)
08:50AM	Despite Fast-paced Momentum, Inotiv, Inc. (NOTV) Is Still a Bargain Stock (Zacks)
Mar-01-24 09:40AM	Should Value Investors Buy Inotiv (NOTV) Stock? (Zacks) +7.25%
Feb-29-24 08:50AM	Here's What Could Help Inotiv, Inc. (NOTV) Maintain Its Recent Price Strength (Zacks) +13.57%
Feb-27-24 01:34PM	3 Overlooked Stocks with Potential for 500% Growth by 2025 (InvestorPlace)
Feb-20-24 07:38AM	Millionaire-Makers: 3 Game-Changing Stocks Ready for Historic Gains (InvestorPlace) +6.52%
Feb-19-24 08:50AM	Inotiv, Inc. (NOTV) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Feb-14-24 09:40AM	Are Investors Undervaluing Inotiv (NOTV) Right Now? (Zacks) +10.23%
Feb-09-24 08:25AM	Inotiv, Inc. (NASDAQ:NOTV) Q1 2024 Earnings Call Transcript (Insider Monkey) +15.35%
Feb-08-24 09:55AM	Inotiv Inc (NOTV) Reports Revenue Growth and Reduced Net Loss in Q1 FY 2024 (GuruFocus.com) +16.85%
08:54AM	Q1 2024 Inotiv Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-07-24 06:10PM	Inotiv, Inc. (NOTV) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Inotiv Reports First Quarter Financial Results for Fiscal 2024 and Provides Business Update (GlobeNewswire)
Jan-29-24 04:05PM	Inotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 2024 (GlobeNewswire) -5.22%
Jan-27-24 09:00AM	Big Pharmas great lab monkey shortage: A crackdown on smuggling is causing chaos in Americas vital drug development pipeline (Fortune)
Dec-16-23 03:01PM	Insider Buying: COO John Beattie Acquires 47,966 Shares of Inotiv Inc (NOTV) (GuruFocus.com)
Dec-15-23 08:50AM	Inotiv, Inc. (NOTV) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Dec-14-23 08:14AM	Inotiv, Inc. (NASDAQ:NOTV) Q4 2023 Earnings Call Transcript (Insider Monkey) +12.32%
Dec-12-23 07:45AM	Q4 2023 Inotiv Inc Earnings Call (Thomson Reuters StreetEvents) -15.84%
Dec-11-23 09:54PM	NOTV Stock Earnings: Inotiv Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -10.36%
04:05PM	Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2023 and Provides Business Update (GlobeNewswire)
Dec-06-23 04:30PM	Inotiv, Inc. Announces Plan to Insource North American Transportation Operations (GlobeNewswire) +14.55%
Nov-27-23 04:05PM	Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023 (GlobeNewswire) -13.73% +6.12%
Nov-13-23 04:05PM	Inotiv Provides Business Updates and Upcoming Investor Conferences Update (GlobeNewswire) +16.48%
Nov-08-23 07:30AM	Inotiv Ranked Number 127 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 (GlobeNewswire)
Nov-01-23 08:00AM	Inotiv, Inc. to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-16-23 08:00AM	Inotiv, Inc. Announces Changes to its Board Composition (GlobeNewswire) +21.95%
Aug-29-23 06:47PM	Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd. (GlobeNewswire)
Aug-24-23 04:05PM	Inotiv, Inc. to Participate in Upcoming September 2023 Investor Conferences (GlobeNewswire) -6.55%
Aug-15-23 03:31PM	Inotiv Faces SEC Probe on Imports of Monkeys From Asia (The Wall Street Journal) -6.86%
Aug-10-23 06:15PM	Inotiv, Inc. (NOTV) Q3 Earnings Miss Estimates (Zacks) -35.63%
04:08PM	Inotiv Reports Third Quarter Financial Results for Fiscal 2023 and Provides Business Update (GlobeNewswire)

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Leasure Robert Jr.	President and CEO	Feb 02 '26	Sale	0.50	113,297	57,034	1,273,025	Feb 03 04:14 PM
Leasure Robert Jr.	Officer	Feb 02 '26	Proposed Sale	0.49	120,000	59,088		Feb 02 02:31 PM
Neff R Matthew	Director	Dec 01 '25	Sale	0.89	2,000	1,771	151,102	Dec 02 04:41 PM
Neff R Matthew	Director	Dec 01 '25	Proposed Sale	0.89	2,000	1,771		Dec 01 11:29 AM
Neff R Matthew	Director	Nov 03 '25	Sale	1.24	2,000	2,487	153,102	Nov 04 05:16 PM
Neff R Matthew	Director	Oct 24 '25	Option Exercise	1.94	10,000	19,400	155,102	Oct 28 04:03 PM
Neff R Matthew	Director	Oct 01 '25	Sale	1.43	2,000	2,858	145,102	Oct 03 04:25 PM
Neff R Matthew	Director	Sep 02 '25	Sale	1.67	2,000	3,338	147,102	Sep 04 10:46 AM
Neff R Matthew	Director	Sep 02 '25	Proposed Sale	1.67	6,000	10,000		Sep 02 11:24 AM
Neff R Matthew	Director	Aug 01 '25	Sale	1.91	2,000	3,818	149,102	Aug 04 04:28 PM
Neff R Matthew	Director	Jul 01 '25	Sale	1.81	2,000	3,621	151,102	Jul 03 04:30 PM
Neff R Matthew	Director	Jun 02 '25	Sale	2.62	2,000	5,246	153,102	Jun 04 04:05 PM
Neff R Matthew	Director	Jun 02 '25	Proposed Sale	2.60	6,000	15,600		Jun 02 10:26 AM
Coelho Mary Theresa	Director	Apr 01 '25	Sale	2.35	5,500	12,916	74,303	Apr 02 04:32 PM
Coelho Mary Theresa	Director	Apr 01 '25	Proposed Sale	2.83	5,500	15,565		Apr 01 06:33 PM
Freeman Jeffrey Brennan	VP-Finance & Corp. Controller	Feb 18 '25	Sale	4.04	1,339	5,416	27,478	Feb 20 04:34 PM
Taylor Beth	Chief Financial Officer	Feb 18 '25	Sale	4.01	4,370	17,507	108,368	Feb 20 04:33 PM
Sagartz John E	Chief Strategy Officer	Feb 18 '25	Sale	3.94	2,113	8,316	707,816	Feb 20 04:33 PM
Leasure Robert Jr.	President and CEO	Feb 18 '25	Sale	3.82	73,617	281,136	956,592	Feb 20 04:32 PM

ELAN Elanco Animal Health Inc daily Stock Chart

Peers: ZTS IDXX ABT MRK SNY PETS BIIB VET RDFN

| Held by: IJH VTI VB VBR VXF MDY XMHQ DFAT IJK SPMD

Index	-	P/E	344.72	EPS (ttm)	0.07	Insider Own	0.92%	Shs Outstand	496.83M	Perf Week	-0.28%
Market Cap	12.49B	Forward P/E	24.50	EPS next Y	1.03	Insider Trans	0.96%	Shs Float	492.28M	Perf Month	2.82%
Enterprise Value	16.01B	PEG	3.07	EPS next Q	0.11	Inst Own	113.37%	Short Float	4.72%	Perf Quarter	13.97%
Income	36.00M	P/S	2.72	EPS this Y	2.53%	Inst Trans	3.12%	Short Ratio	4.61	Perf Half Y	39.61%
Sales	4.59B	P/B	1.85	EPS next Y	9.92%	ROA	0.27%	Short Interest	23.23M	Perf YTD	11.05%
Book/sh	13.58	P/C	24.73	EPS next 5Y	7.98%	ROE	0.54%	52W High	26.08 -3.62%	Perf Year	115.52%
Cash/sh	1.02	P/FCF	33.93	EPS past 3/5Y	- 29.95%	ROIC	0.34%	52W Low	8.02 213.34%	Perf 3Y	92.71%
Dividend Est.	-	EV/EBITDA	17.57	Sales past 3/5Y	-2.33% 7.65%	Gross Margin	43.32%	Volatility	2.93% 3.05%	Perf 5Y	-15.53%
Dividend TTM	-	EV/Sales	3.49	EPS Y/Y TTM	-82.39%	Oper. Margin	5.25%	ATR (14)	0.76	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.23	Sales Y/Y TTM	3.08%	Profit Margin	0.78%	RSI (14)	57.48	Recom	1.56
Dividend Gr. 3/5Y	- -	Current Ratio	2.40	EPS Q/Q	-109.35%	SMA20	1.93%	Beta	1.84	Target Price	26.42
Payout	0.00%	Debt/Eq	0.60	Sales Q/Q	10.39%	SMA50	7.47%	Rel Volume	0.66	Prev Close	24.79
Employees	9450	LT Debt/Eq	0.59	Earnings	Feb 24 BMO	SMA200	34.51%	Avg Volume	5.04M	Price	25.13
IPO	Sep 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	46.15% 4.14%	Trades		Volume	3,343,477	Change	1.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-22-26	Upgrade	Piper Sandler	Neutral → Overweight
Dec-09-25	Initiated	Barclays	Overweight	$30
Nov-21-25	Initiated	KeyBanc Capital Markets	Overweight	$27
Nov-19-25	Upgrade	Argus	Hold → Buy	$25
Oct-07-25	Upgrade	JP Morgan	Neutral → Overweight	$24
Jul-17-25	Upgrade	Leerink Partners	Market Perform → Outperform	$18
Jun-26-25	Upgrade	William Blair	Mkt Perform → Outperform
Dec-09-24	Initiated	UBS	Buy	$18
Dec-02-24	Initiated	Leerink Partners	Market Perform	$14
Sep-19-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$17 → $15
Jan-05-24	Upgrade	Stifel	Hold → Buy	$13 → $20
Dec-19-23	Initiated	Jefferies	Buy	$17
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$16
Dec-07-23	Initiated	Exane BNP Paribas	Outperform	$18
Apr-20-23	Upgrade	Barclays	Equal Weight → Overweight	$14
Aug-18-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$37 → $22
Aug-16-22	Downgrade	JP Morgan	Overweight → Neutral	$28 → $24
Jul-21-22	Downgrade	Goldman	Buy → Sell	$32 → $19
Jul-12-22	Initiated	Piper Sandler	Neutral	$22
Nov-18-21	Initiated	Morgan Stanley	Overweight	$40

Show Previous Ratings

Feb-13-26 09:24AM	Elanco Announces Updates to Board of Directors (PR Newswire)
Feb-10-26 06:41AM	Here's What the Street Thinks About Elanco Animal Health Incorporated (ELAN) (Insider Monkey)
Jan-30-26 11:56AM	Can Operational Execution Support DaVita's Q4 Performance? (Zacks)
Jan-28-26 07:50AM	Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health (ELAN) (Insider Monkey)
Jan-27-26 04:04PM	Gold and Silver Arent the Only Hot Commodities. Agricultural Stocks to Consider. (Barrons.com)
11:35PM	Loading…
Jan-26-26 11:35PM	2 Profitable Stocks to Own for Decades and 1 Facing Headwinds (StockStory)
Jan-22-26 04:36PM	Stocks Settle Higher as Global Tensions Cool and the Economy Expands (Barchart)
08:00AM	Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement (PR Newswire)
06:00AM	Companies Move to Refinance Sooner: Better Off to Lock It In (The Wall Street Journal)
Jan-12-26 06:54PM	Elanco CEO: Gaining Market Share Via 'Major' Innovations (Bloomberg)
Jan-06-26 11:08PM	3 Reasons to Avoid ELAN and 1 Stock to Buy Instead (StockStory)
06:52PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
08:00AM	Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-25 02:00PM	Elanco Receives USDA Approval for Befrena (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis (PR Newswire)
Dec-21-25 10:07AM	Jim Cramer on Elanco Animal Health: "They Are Doing Everything Right" (Insider Monkey)
01:30AM	Loading…
Dec-19-25 01:30AM	Elanco CEO Bites Off More Shares of Fast-Rising Stock (Barrons.com)
Dec-18-25 08:43AM	Elanco's Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs (PR Newswire)
Dec-16-25 02:05PM	Elanco (ELAN) Stock Is Up, What You Need To Know (StockStory)
09:40AM	Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year? (Zacks)
Dec-12-25 12:00PM	All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy (Zacks)
Dec-09-25 04:15PM	How Protein And Pets Drove Elanco Animal Health's Double-Digit Gain In 2025 (Investor's Business Daily) -5.81%
07:40AM	Elanco Investor Day Defines New Era as Sustainable Growth Company (PR Newswire)
Nov-24-25 07:00PM	Elanco, AMN Healthcare Services, Brookdale, DexCom, and Addus HomeCare Shares Skyrocket, What You Need To Know (StockStory)
Nov-21-25 01:35PM	Elanco's Credelio CAT (lotilaner) Receives First FDA Emergency Use Authorization (EUA) for Treatment of New World Screwworm (NWS) in Cats (PR Newswire)
Nov-20-25 08:00AM	Elanco to Participate in the Upcoming Investor Conferences (PR Newswire)
Nov-14-25 09:03AM	Pet Healthcare Spending Is Soaring. These 5 Stocks Are Positioned to Clean Up (24/7 Wall St.)
Nov-13-25 08:00AM	Alloy Partners Launches OneHealth Studio to Create Startups at the Convergence of Animal, Plant and Human Health (PR Newswire)
Nov-12-25 12:35AM	5 Revealing Analyst Questions From Elanco's Q3 Earnings Call (StockStory)
Nov-11-25 08:46AM	Are Options Traders Betting on a Big Move in Elanco Animal Health Stock? (Zacks)
Nov-06-25 12:33AM	ELAN Q3 Deep Dive: Innovation Drives Growth, but Market Eyes Margin and Competition (StockStory)
07:26PM	Loading…
Nov-05-25 07:26PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
03:12PM	Elanco Animal Health CEO: Seeing a willingness to spend, durability even in 'consumer tested' time (CNBC TV)
02:01PM	Elanco Animal Health Inc (ELAN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
09:30AM	Compared to Estimates, Elanco Animal Health (ELAN) Q3 Earnings: A Look at Key Metrics (Zacks)
07:35AM	Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:36AM	Elanco (NYSE:ELAN) Surprises With Q3 Sales (StockStory)
06:27AM	Elanco Animal Health Reports Third Quarter 2025 Results (PR Newswire)
Nov-03-25 10:19PM	Elanco (ELAN) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
04:28PM	How Idexx Laboratories Business Shook Off Bears And Hit A Record (Investor's Business Daily)
Oct-29-25 10:00AM	Elanco Animal Health Incorporated (ELAN) Reports Next Week: What You Should Expect (Zacks)
Oct-28-25 11:27AM	Can Technology and Cost Discipline Lift DaVita's Q3 Earnings? (Zacks)
Oct-27-25 06:27AM	Elanco Announces Expansion of Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species (PR Newswire)
Oct-24-25 05:33PM	Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment (The Wall Street Journal)
04:55PM	Elanco's Credelio (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs (PR Newswire)
12:02AM	Elanco (ELAN): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Oct-23-25 11:40AM	ELAN vs. USPH: Which Stock Is the Better Value Option? (Zacks)
Oct-22-25 09:40AM	Is Elanco Animal Health (ELAN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-20-25 02:03PM	West Pharmaceutical Services Stock Sees RS Rating Climb To 71 (Investor's Business Daily)
Oct-17-25 06:39PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
Oct-16-25 04:32PM	Elanco to Host Investor Day on December 9 (PR Newswire)
Oct-08-25 12:00PM	Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy? (Zacks)
Oct-07-25 11:31AM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
Oct-06-25 11:40AM	ELAN or USPH: Which Is the Better Value Stock Right Now? (Zacks)
05:15AM	Best Value Stocks to Buy for October 6th (Zacks)
Oct-01-25 08:00AM	Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement (PR Newswire)
Sep-30-25 12:00PM	Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-24-25 12:01PM	Why Elanco (ELAN) Stock Is Up Today (StockStory)
Sep-23-25 07:10PM	Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up (Insider Monkey)
06:27AM	Elanco Announces FDA Approves Improved Zenrelia (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language (PR Newswire)
Sep-11-25 10:57PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
Sep-08-25 03:35PM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
06:27AM	Elanco Innovation Builds Momentum, Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status (PR Newswire)
Sep-03-25 02:45PM	Why Elanco (ELAN) Stock Is Trading Lower Today (StockStory)
Sep-01-25 11:31PM	Unpacking Q2 Earnings: Elanco (NYSE:ELAN) In The Context Of Other Pharmaceuticals Stocks (StockStory)
Aug-27-25 12:31PM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
08:00AM	Splenda Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and Education (PR Newswire)
Aug-26-25 06:15PM	Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600 (PR Newswire)
08:00AM	Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
Aug-14-25 01:34AM	5 Insightful Analyst Questions From Elanco's Q2 Earnings Call (StockStory)
Aug-12-25 03:25AM	ELAN Q2 Deep Dive: Innovation and Execution Drive Raised Full-Year Outlook (StockStory)
Aug-08-25 06:57PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
11:53AM	Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost (Insider Monkey)
Aug-07-25 02:13PM	Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4% (StockStory) +18.14%
12:23PM	Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook (Benzinga)
09:30AM	Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
07:35AM	Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates (Zacks)
06:59AM	Elanco Animal Health Raises 2025 Guidance (RTT News)
06:27AM	Elanco Animal Health Reports Second Quarter 2025 Results (PR Newswire)
Aug-06-25 06:15PM	U.S. Physical Therapy (USPH) Tops Q2 Earnings and Revenue Estimates (Zacks)
09:15AM	Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Aug-05-25 11:11PM	What To Expect From Elanco's (ELAN) Q2 Earnings (StockStory)
Aug-04-25 05:45PM	Addus HomeCare (ADUS) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
Jul-31-25 01:16PM	Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings? (Zacks)
Jul-25-25 03:36PM	Why Elanco (ELAN) Stock Is Trading Up Today (StockStory)
Jul-24-25 05:42PM	Elanco Secures Approval of Zenrelia (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs (PR Newswire)
11:40AM	ELAN vs. USPH: Which Stock Is the Better Value Option? (Zacks)
Jul-22-25 09:40AM	Are Medical Stocks Lagging Encompass Health (EHC) This Year? (Zacks)
Jul-21-25 04:11AM	Veterinary Dermatology - Company Evaluation Report 2025 \| Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion (GlobeNewswire)
Jul-17-25 09:46AM	Starbucks downgraded, Oracle initiated: Wall Street's top analyst calls (The Fly)
Jul-15-25 10:35AM	Are Options Traders Betting on a Big Move in ELAN Stock? (Zacks)
Jul-10-25 08:00AM	Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement (PR Newswire)
Jul-09-25 08:27AM	Elanco Receives USDA Approval for TruCan Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection (PR Newswire)
Jul-02-25 07:00AM	Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 (PR Newswire)
Jun-30-25 07:25AM	5 Revealing Analyst Questions From Elanco's Q1 Earnings Call (StockStory)
Jun-26-25 01:00PM	Elanco Releases 2024 Impact Report and Introduces New Framework (PR Newswire)
09:49AM	General Mills upgraded, Trade Desk downgraded: Wall Street's top analyst calls (The Fly)
Jun-18-25 12:46PM	Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. (Barrons.com)
Jun-12-25 04:17PM	Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) (PR Newswire)
Jun-11-25 04:25AM	ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty (StockStory)
Jun-10-25 12:00PM	What Makes Elanco Animal Health (ELAN) a New Buy Stock (Zacks)

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kurzius Lawrence Erik	Director	Dec 12 '25	Buy	21.30	10,000	213,000	131,773	Dec 16 04:42 PM
Modi Rajeev A.	SEE REMARKS	Dec 11 '25	Buy	21.33	4,500	95,985	123,082	Dec 15 04:43 PM
VanHimbergen Robert M	EVP and CFO	Dec 11 '25	Buy	21.64	6,950	150,426	124,233	Dec 15 04:42 PM
Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR	Dec 11 '25	Buy	21.75	22,000	478,496	167,000	Dec 15 04:41 PM
Todd S and Jennifer G Young Li	Former CFO	Aug 11 '25	Proposed Sale	16.82	49,333	830,000		Aug 11 03:58 PM
Kurzius Lawrence Erik	Director	Mar 07 '25	Buy	10.90	10,000	109,000	101,459	Mar 11 05:13 PM
Kurzius Lawrence Erik	Director	Mar 11 '25	Buy	10.20	10,000	102,000	111,459	Mar 11 05:13 PM
HOOVER R DAVID	Director	Mar 05 '25	Buy	10.90	25,000	272,558	210,000	Mar 07 04:21 PM

NOTV

Inotiv Inc

ELAN

Elanco Animal Health Inc

Upgrade your FINVIZ experience